共 145 条
[31]
Pickering S(2018)The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity J Pharm Sci 107 146-55
[32]
Dunne T(2007)Evaluation of the effects of animal growth and previous exposure on the pharmacokinetics of rituximab in rats Clin Immunol 122 3815-8
[33]
Zhang S(1997)Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model Blood 90 382-9
[34]
Shi R(2012)IgG biosynthesis: no "immunoregulatory feedback" Am J Forensic Med Pathol 33 67-86
[35]
Li C(2012)Organ weight changes associated with body mass index determined from a medical autopsy population J Pharmacokinet Pharmacodyn 39 1640-52
[36]
Parivar K(2005)Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human Ann Biomed Eng 33 687-709
[37]
Wang DD(2007)A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal Fc receptor (FcRn) J Pharmacokinet Pharmacodyn 34 248-55
[38]
Rutter A(2013)Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice Drug Metab Dispos 41 146-8
[39]
Luger TA(2014)Mechanisms of subcutaneous absorption of rituximab in rats Clin Exp Immunol 178 78-82
[40]
Jolles S(1984)Subcutaneous immunoglobulin loading regimens for previously untreated patients with primary antibody deficiency Am J Med 76 S525-53